Why Yale Urology
At Yale Urology, we understand that a diagnosis of kidney cancer can profoundly impact your life and leave you and your loved ones with many questions about your journey ahead. Our team members are dedicated to providing the compassionate care, support, and information you need to move forward confidently with your treatment process.
We will help you fully understand your diagnosis, treatment, and management options available. We are committed to offering our patients with early- and late-stage kidney cancer the most advanced diagnostic technologies and treatment strategies available. Our surgeons meet regularly with the multidisciplinary specialists of Yale-New Haven Hospital and Smilow Cancer Hospital to discuss every patient's care and develop a comprehensive treatment plan unique to each patient. This level of collaboration brings the medical management of our cancer patients to the highest level.
Yale Urology surgeons are at the forefront of cancer research, driving the search for new treatments and cures and staying current on the most advanced and effective techniques. We continually integrate the latest in science-based medicine and innovative approaches into our practice to offer patients safer and more effective treatments.
Using the most advanced minimally invasive techniques, such as robotic-assisted surgery, our surgeons can personalize their approach to treating kidney cancer. Minimally invasive and robotic-assisted surgeries performed by our surgeons include laparoscopic partial nephrectomy and laparoscopic full nephrectomy.
About Kidney Cancer
Kidney cancer is a malignancy in the kidneys.
The kidneys’ main function is to produce urine, but by adjusting the composition of the urine, they also regulate electrolytes, bodily fluids, the body’s acid-base balance, and they eliminate waste products produced by the body.
The most common type of kidney cancer, making up about 90 percent of cases, is renal cell carcinoma (RCC). RCC is the most common type of kidney cancer. This type of cancer originates in the lining of the kidney tubules and generally grows as a single mass. Occasionally, more than one tumor may grow in a kidney or tumors may grow in both kidneys. There are five subtypes of RCC, which are classified according to their cellular shape: clear cell, papillary, chromophobe, collecting duct, and “unclassified.”
The remaining 10 percent of kidney tumors are made up of less common types, which include transitional cell carcinomas, Wilms’ tumors, and renal sarcomas.
Additional information about kidney cancer: